Amara Gul, Javed Yousaf.
Alexithymia Predicts Cognitive Deficits in patients with Indiopathic Parkinson`s Disease.
J Ayub Med Coll Abottabad Jan ;31(1):21-5.

Background: In recent years, alexithymia has gained attention of medical researchers as a prognostic factor for serious health problems. The present study aimed to assess alexithymia as a determinant of cognitive decline in patients with Parkinson?s disease. Methods: Patients diagnosed with Parkinson?s disease (n=60) at Bahawal Victoria Hospital, Civil Hospital Bahawalpur and Nishter Hospital Multan during May 2016 until June 2017 participated in the study. Healthy individuals (n=60) took part in the study from local community as controls. Participants completed Bermond-Vorst Alexithymia Questionnaire and Montreal Cognitive Assessment. It was a cross sectional study design. Purposive sampling technique was used and data was analysed through multivariate analysis of variance and bivariate correlation. Results: Patients with Parkinson?s disease (177.96±8.93) showed higher attitudes of alexithymia as compared with healthy individuals (37.46±8.01), F (1,118) = 8216.52, p<0.001, ?p2 =.98. In contrast with healthy controls (28.60±0.58), patients with Parkinson?s disease (2.25±.95) were cognitively impaired F (1,118) =36424.38, p<0.001, ?p2 =.99. Alexithymia was a significant predictor of cognitive performance (R2 =0.99, F (2, 119) = 5698.95, p<0.001). Conclusion: Alexithymia is a significant marker of cognitive decline in patients with Parkinson?s disease.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com